Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiation

Brian P Hibler; Christopher A Barker; Travis J Hollmann; Anthony M Rossi

doi:10.1016/j.jdcr.2017.03.006

Metastatic cutaneous apocrine carcinoma: Multidisciplinary approach achieving complete response with adjuvant chemoradiation

JAAD Case Rep. 2017 May 27;3(3):259-262. doi: 10.1016/j.jdcr.2017.03.006. eCollection 2017 May.

Authors

Brian P Hibler¹, Christopher A Barker², Travis J Hollmann³, Anthony M Rossi¹

Affiliations

¹ Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
² Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.

No abstract available

Keywords: ER, estrogen receptor; MSK-IMPACT; MSK-IMPACT, Memorial Sloan Kettering–Integrated Mutation Profiling of Actionable Cancer Targets; PET, positron emission tomography; PR, progesterone receptor; adenocarcinoma; adnexal; apocrine; cytotoxic chemotherapy; immunohistochemistry; metastatic; multidisciplinary; radiation; skin cancer.

Publication types

Case Reports

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States